Dermoscopy could be useful in differentiating sarcoidosis from necrobiotic granulomas even after treatment with systemic steroids

Background: Diagnosing cutaneous sarcoidosis and necrobiotic granulomas is challenging. Objective: Assessing the value of dermoscopy in differentiating cutaneous sarcoidosis from necrobiotic granulomas and evaluating whether their dermoscopic features will be altered after treatment. Meth...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shahira Ramadan, Dalia Hossam, Marwah A. Saleh
Formato: article
Lenguaje:EN
Publicado: Mattioli1885 2016
Materias:
Acceso en línea:https://doaj.org/article/7c01e194a4a94796ab5b1b3c67d464dc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7c01e194a4a94796ab5b1b3c67d464dc
record_format dspace
spelling oai:doaj.org-article:7c01e194a4a94796ab5b1b3c67d464dc2021-11-17T08:31:13ZDermoscopy could be useful in differentiating sarcoidosis from necrobiotic granulomas even after treatment with systemic steroids10.5826/dpc.0603a052160-9381https://doaj.org/article/7c01e194a4a94796ab5b1b3c67d464dc2016-07-01T00:00:00Zhttp://dpcj.org/index.php/dpc/article/view/29https://doaj.org/toc/2160-9381 Background: Diagnosing cutaneous sarcoidosis and necrobiotic granulomas is challenging. Objective: Assessing the value of dermoscopy in differentiating cutaneous sarcoidosis from necrobiotic granulomas and evaluating whether their dermoscopic features will be altered after treatment. Methods: Nineteen cutaneous sarcoidosis and 11 necrobiotic granuloma patients (2 necrobiosis lipoidica, 4 granuloma annulare and 5 rheumatoid nodule) were included in this study. The diagnosis was confirmed by skin biopsy. The lesions were examined using non-contact polarized dermoscope (Dermlite 2 HR-Pro; 3Gen, San Juan Capistrano, CA). Results: Ten out of 19 cutaneous sarcoidosis patients and 7/11 necrobiotic cases group were receiving treatments (topical, intralesional or systemic steroids ± chloroquine) but still have cutaneous lesions. Treatment duration in the sarcoidosis group ranged from 2 months to 10 years (median 3 years) and in the necrobiotic cases group ranged from 3 months to 16 years (median 2 years). Pink homogenous background, translucent orange areas, white scar-like depigmentation and fine white scales were significantly associated with the cutaneous sarcoidosis compared to necrobiotic cases group. On the other hand mixed pink, white and yellowish background was significantly associated with the necrobiotic cases group. No significant difference in the dermoscopic findings was detected between treated and non-treated patients. Conclusion: Some dermoscopic findings are shared between the cutaneous sarcoidosis group and the necrobiotic cases group, yet dermoscopy could be a useful aid in differentiating them even after treatment. Shahira RamadanDalia HossamMarwah A. SalehMattioli1885articlecutaneous sarcoidosisdermoscopynecrobiotic granulomasteroidstreatmentDermatologyRL1-803ENDermatology Practical & Conceptual (2016)
institution DOAJ
collection DOAJ
language EN
topic cutaneous sarcoidosis
dermoscopy
necrobiotic granuloma
steroids
treatment
Dermatology
RL1-803
spellingShingle cutaneous sarcoidosis
dermoscopy
necrobiotic granuloma
steroids
treatment
Dermatology
RL1-803
Shahira Ramadan
Dalia Hossam
Marwah A. Saleh
Dermoscopy could be useful in differentiating sarcoidosis from necrobiotic granulomas even after treatment with systemic steroids
description Background: Diagnosing cutaneous sarcoidosis and necrobiotic granulomas is challenging. Objective: Assessing the value of dermoscopy in differentiating cutaneous sarcoidosis from necrobiotic granulomas and evaluating whether their dermoscopic features will be altered after treatment. Methods: Nineteen cutaneous sarcoidosis and 11 necrobiotic granuloma patients (2 necrobiosis lipoidica, 4 granuloma annulare and 5 rheumatoid nodule) were included in this study. The diagnosis was confirmed by skin biopsy. The lesions were examined using non-contact polarized dermoscope (Dermlite 2 HR-Pro; 3Gen, San Juan Capistrano, CA). Results: Ten out of 19 cutaneous sarcoidosis patients and 7/11 necrobiotic cases group were receiving treatments (topical, intralesional or systemic steroids ± chloroquine) but still have cutaneous lesions. Treatment duration in the sarcoidosis group ranged from 2 months to 10 years (median 3 years) and in the necrobiotic cases group ranged from 3 months to 16 years (median 2 years). Pink homogenous background, translucent orange areas, white scar-like depigmentation and fine white scales were significantly associated with the cutaneous sarcoidosis compared to necrobiotic cases group. On the other hand mixed pink, white and yellowish background was significantly associated with the necrobiotic cases group. No significant difference in the dermoscopic findings was detected between treated and non-treated patients. Conclusion: Some dermoscopic findings are shared between the cutaneous sarcoidosis group and the necrobiotic cases group, yet dermoscopy could be a useful aid in differentiating them even after treatment.
format article
author Shahira Ramadan
Dalia Hossam
Marwah A. Saleh
author_facet Shahira Ramadan
Dalia Hossam
Marwah A. Saleh
author_sort Shahira Ramadan
title Dermoscopy could be useful in differentiating sarcoidosis from necrobiotic granulomas even after treatment with systemic steroids
title_short Dermoscopy could be useful in differentiating sarcoidosis from necrobiotic granulomas even after treatment with systemic steroids
title_full Dermoscopy could be useful in differentiating sarcoidosis from necrobiotic granulomas even after treatment with systemic steroids
title_fullStr Dermoscopy could be useful in differentiating sarcoidosis from necrobiotic granulomas even after treatment with systemic steroids
title_full_unstemmed Dermoscopy could be useful in differentiating sarcoidosis from necrobiotic granulomas even after treatment with systemic steroids
title_sort dermoscopy could be useful in differentiating sarcoidosis from necrobiotic granulomas even after treatment with systemic steroids
publisher Mattioli1885
publishDate 2016
url https://doaj.org/article/7c01e194a4a94796ab5b1b3c67d464dc
work_keys_str_mv AT shahiraramadan dermoscopycouldbeusefulindifferentiatingsarcoidosisfromnecrobioticgranulomasevenaftertreatmentwithsystemicsteroids
AT daliahossam dermoscopycouldbeusefulindifferentiatingsarcoidosisfromnecrobioticgranulomasevenaftertreatmentwithsystemicsteroids
AT marwahasaleh dermoscopycouldbeusefulindifferentiatingsarcoidosisfromnecrobioticgranulomasevenaftertreatmentwithsystemicsteroids
_version_ 1718425746168348672